Treatment outcome of HCV single vs multi tablet regimen in mono and HIV co-infected people who use drugs (PWUD): a long-term follow-up analysis

被引：0
|
作者：
Thiam, A. [1 ]
Yamamoto, L. [1 ]
Sian, P. [1 ]
Rhee, D. [1 ]
Conway, B. [1 ]
Magel, T. [1 ]
Wuerth, K. [1 ]
机构：
[1] VIDC, Vancouver, BC, Canada
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PE37/40
引用
收藏
页码：307 / 307
页数：1
相关论文
共 9 条
  • [1] Long-term follow-up of people who use drugs (PWUD) following HCV infection therapy: drug use patterns among HIV co-infected versus mono-infected patients
    Thiam, A.
    Sian, P.
    Yamamoto, L.
    Rhee, D.
    Magel, T.
    Wuerth, K.
    Conway, B.
    [J]. HIV MEDICINE, 2019, 20 : 306 - 306
  • [2] LONG-TERM FOLLOW-UP OF PEOPLE WHO USE DRUGS (PWUD) FOLLOWING HCV INFECTION THERAPY: DRUG USE PATTERNS AND MAINTENANCE OF A SUSTAINED VIROLOGIC RESPONSE (SVR).
    Thiam, Astou
    Sian, Priya
    Conway, Brian
    Magel, Tianna
    Wuerth, Kelli
    Truong, David
    [J]. HEPATOLOGY, 2019, 70 : 949A - 950A
  • [3] Long-term follow-up of co-infected HIV and Trypanosoma cruzi Brazilian patients
    Da-Cruz, AM
    Igreja, RP
    Dantas, W
    Junqueira, ACV
    Pacheco, RS
    Silva-Gonçalves, AJ
    Pirmez, C
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2004, 98 (12) : 728 - 733
  • [4] Long-term follow-up of HIV-HBV co-infected patients according to the use of anti-HBV active drugs
    Calcagno, A.
    Alessandro, C.
    Saracino, A.
    De Luca, A.
    Colella, E.
    Cingolani, A.
    Sarmati, L.
    Ceccherini-Silberstein, F.
    Antinori, A.
    Puoti, M.
    Perno, C.
    Monforte, A. D'Arminio
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [5] Direct-acting antiviral treatment of chronic hepatitis C: a single-centre outcome analysis in both HIV/HCV co-infected and HCV mono-infected patients
    Chen, L.
    Lee, T. H.
    Vora, N.
    Sultan, B.
    Reid, D.
    Dakshina, S.
    Gilson, R.
    Waters, L.
    Ghosh, I.
    [J]. HIV MEDICINE, 2018, 19 : S149 - S149
  • [6] Similar rates of HCV recurrence in HCV/HIV co-infected and HCV mono-infected patients who achieved SVR after DAA treatment: interim results from the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
    Wyles, David L.
    Kang, Minhee
    Matining, Roy
    Murphy, Robert
    Peters, Marion G.
    [J]. HEPATOLOGY, 2017, 66 : 523A - 524A
  • [7] No evidence of fibrosis regression in HCV/HIV co-infected and HCV monoinfected participants up to 3 years after achieving SVR with DAA treatment: Interim results for the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
    Peters, M.
    Kang, M.
    Murphy, R.
    Matining, R.
    Rosenberg, W.
    Wyles, D.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S545 - S545
  • [8] Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018
    Nyamankolly, Elsa
    Bellecave, Pantxika
    Wittkop, Linda
    Le Marec, Fabien
    Duffau, Pierre
    Lazaro, Estibaliz
    Vareil, Marc-Olivier
    Tumiotto, Camille
    Hessamfar, Mojgan
    Cazanave, Charles
    Perrier, Adelaide
    Leleux, Olivier
    Bonnet, Fabrice
    Neau, Didier
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (01)
  • [9] Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs
    Grando, Sergei A.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (01) : 114 - 125
1